The Trump administration is reportedly moving to reclassify marijuana, potentially easing federal restrictions. This change would shift it from a Schedule One drug to a Schedule Three drug, making research easier and carrying various legal implications. However, it would still be controlled and not treated like a common substance. The publics view on marijuana has shifted, with nearly two-thirds of Americans believing it should be legal. Rescheduling is different from descheduling, meaning existing criminal cases would not be impacted. The final approval rests with the Drug Enforcement Administration, which could present a challenge. This reclassification could bring benefits to the cannabis industry, such as making banks more comfortable doing business with dispensaries and improving tax policy.

DNN | The Daily News Now!

The world’s first global local news network.

Every city. Every story. AI powered. 

Hosted on Acast. See acast.com/privacy for more information.